Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diabetes Mellitus Type 2 - Insulin-Treated”

574 trials

Showing 20 of 574 results

Post-approval studies (Phase 4)Study completedNCT03338855
What this trial is testing

Effects of 5 Weeks Treatment With Dapagliflozin in Type 2 Diabetes Patients on How the Hormone Insulin Acts on Sugar Uptake in Muscles.

Who this might be right for
Diabetes Mellitus, Type 2Skeletal Muscle Insulin Sensitivity
AstraZeneca 26
Not applicableStudy completedNCT03362762
What this trial is testing

Characteristics of Type 2 Diabetes Patients, Treated With Insulin and Their Follow up Care in Guadeloupe

Who this might be right for
Type 2 Diabetes Treated With Insulin
Centre Hospitalier Universitaire de la Guadeloupe 205
Post-approval studies (Phase 4)Study completedNCT02582242
What this trial is testing

Comparing Efficacy and Safety of Thrice Daily Versus Twice Daily NovoMix® 30 (Biphasic Insulin Aspart 30) in Subjects With Type 2 Diabetes Inadequately Controlled With Basal Insulin

Who this might be right for
DiabetesType 2 Diabetes Mellitus
Novo Nordisk A/S 437
Not applicableStudy completedNCT03490747
What this trial is testing

Evaluation of a Physical Activity Referral Scheme

Who this might be right for
Cardiovascular Risk FactorDiabetes Mellitus, Type 2Anxiety+7 more
Paula Watson 68
Not applicableStudy completedNCT04829903
What this trial is testing

Dulaglutide Versus Liraglutide in Obese Type 2 Diabetic Adolescents Using Metformin

Who this might be right for
Type 2 Diabetes Treated With InsulinObesityAdolescent Obesity
Corporacion Parc Tauli 116
Large-scale testing (Phase 3)Study completedNCT03610412
What this trial is testing

Cinnamomum Cassia Effect on IGF1 and Metabolic Control in Patients With DM2 Without Glycemic Control Metformin Treated

Who this might be right for
Diabetes Mellitus, Type 2
Coordinación de Investigación en Salud, Mexico 28
Large-scale testing (Phase 3)Study completedNCT00641056
What this trial is testing

Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3)

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 467
Not applicableStudy completedNCT04123054
What this trial is testing

A Novel mHealth Application Guided by an Optimization Algorithm for T1D Sensor-Augmented Insulin Injection Users

Who this might be right for
Diabetes MellitusDiabetes Mellitus, Type 1
McGill University 84
Not applicableStudy completedNCT01859598
What this trial is testing

Observational Registry for Basal Insulin Treatment Study (ORBIT)

Who this might be right for
Diabetes
The George Institute for Global Health, China 19,894
Large-scale testing (Phase 3)Study completedNCT00935532
What this trial is testing

Study to Evaluate the Efficacy and Safety of Exenatide Once-Weekly Injection Compared to Once-Daily Insulin in Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 427
Post-approval studies (Phase 4)Study completedNCT00970528
What this trial is testing

Glucose Reduction by Early Acarbose Treatment in Basal Insulin

Who this might be right for
Diabetes Mellitus, Type 2
Bayer 124
Post-approval studies (Phase 4)Study completedNCT01461577
What this trial is testing

Effectiveness and Safety of Treatment of Insulin Glargine in Type 2 Diabetes Mellitus Following Glucagon-like Peptide-1 (GLP-1) Failure

Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 89
Post-approval studies (Phase 4)Study completedNCT00742976
What this trial is testing

Effects of Insulin Detemir and NPH Insulin on Renal Handling of Sodium, Fluid Retention, and Weight in Type 2 Diabetic Patients

Who this might be right for
Diabetes Type 2Weight Gain
Rigshospitalet, Denmark 24
Not applicableUnknownNCT01310452
What this trial is testing

Study on Liver Fat Content and Visceral Fat Mass in Overweight and Obese Type 2 Diabetes Patients After Treatment With Basal Insulin

Who this might be right for
Type 2 Diabetes Mellitus
Fudan University 50
Testing effectiveness (Phase 2)Study completedNCT00755846
What this trial is testing

Safety and Efficacy Study of Alogliptin on Glycemic Control in Subjects With Type 2 Diabetes.

Who this might be right for
Diabetes Mellitus
Takeda 265
Large-scale testing (Phase 3)Study completedNCT01680341
What this trial is testing

Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 272
Large-scale testing (Phase 3)Study completedNCT02229383
What this trial is testing

Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
AstraZeneca 464
Not applicableStudy completedNCT05893797
What this trial is testing

LY8888AX in Participants Using a Connected Insulin Management Platform

Who this might be right for
Type 1 DiabetesType 2 DiabetesType 2 Diabetes Treated With Insulin
Eli Lilly and Company 36
Large-scale testing (Phase 3)Study completedNCT00328627
What this trial is testing

Efficacy and Safety of Alogliptin Combined With Pioglitazone in Treating Subjects With Type 2 Diabetes Mellitus.

Who this might be right for
Type 2 Diabetes Mellitus
Takeda 1,554
Not applicableStudy completedNCT01492218
What this trial is testing

Observational Study With Mixtard® 30 NovoLet® to Assess Patient Satisfaction

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 1,330
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation